Tuesday
BioTech Webinars
Oct. 27th
1
11:00 am – 12:00 pm ET
Where is the growing science and its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
Category: Chronic conditions
Chair:
Dr. Michael Rosenblatt, MD
Chief Medical Officer
Flagship Pioneering, Cambridge, MA
See here :
Moderator: Lorem Ipsum, Clinical Research Consultants and HumanOptics AG, Clinical Research Consultants and HumanOptics AG
WHO IS SPEAKING
Eric M Pearlman
Senior Medical Director-Neuroscience, US Medical Affairs
Eli Lilly and Company
Dan Cua, PhD
Vice President
IL-23 Pathway Area Leader for the Immunology Therapeutic Area
Janssen Biotech, Inc.
Dr. Mads Frederik Rasmussen
Corporate Project Vice President (CPVP) for GLP-1, CV and Outcomes
Novo Nordisk A/S
Marcella Ruddy
Vice President, Strategic Program Direction, Immunology and Inflammation
Regeneron
2
12:00 pm – 1:15 pm ET
Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
Category: Cancer, other rare conditions and vaccines
Moderator:
Michael Ringel, JD PhD
Managing Director and Senior Partner
BCG
See here :
Moderator: Lorem Ipsum, Clinical Research Consultants and HumanOptics AG, Clinical Research Consultants and HumanOptics AG
Moderator: Lorem Ipsum, Clinical Research Consultants and HumanOptics AG, Clinical Research Consultants and HumanOptics AG
WHO IS SPEAKING
Beth-Ann Coller, PhD
Executive Director, Global Clinical Development
Merck & Co., Inc
3
1:30 pm – 2:45 pm ET
Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
Category: Rare Genetic Disorders
Moderator:
Tanya Lewis
Associate Editor for Health and Medicine
Scientific American
See here :
Moderator: Lorem Ipsum, Clinical Research Consultants and HumanOptics AG, Clinical Research Consultants and HumanOptics AG
WHO IS SPEAKING
Pushkal Garg, MD
Chief Medical Officer
Alnylam
> More about the product (GIVLAARI)
> More about the product (ONPATTRO®)
Jonathan Sorof, M.D.
Senior Vice President, Head of Medical Affairs
Global Blood Therapeutics
